Article on results of combo trial (ipi & nivo)

› Forums › General Melanoma Community › Article on results of combo trial (ipi & nivo)

  • Post
Viewing 5 reply threads
  • Replies
      • June 1, 2015 at 1:52 am
      Bubbles
      Participant

        Thanks for sharing, Maggie!  Here is the synopsis of an artice from ASCO from the CheckMate 069 study…ipi plus nivo vs ipi alone.  It had a little bit different take on what groups experienced a higher response rate for the combo.  Hopefully things will become clearer as to what meds or combo's work best for which patients soon.  http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2015/05/asco-2015-nivo-plus-ipi-vs-ipi-alone.html

        Wishing you all my best.  Celeste

        • June 1, 2015 at 1:52 am
        Bubbles
        Participant

          Thanks for sharing, Maggie!  Here is the synopsis of an artice from ASCO from the CheckMate 069 study…ipi plus nivo vs ipi alone.  It had a little bit different take on what groups experienced a higher response rate for the combo.  Hopefully things will become clearer as to what meds or combo's work best for which patients soon.  http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2015/05/asco-2015-nivo-plus-ipi-vs-ipi-alone.html

          Wishing you all my best.  Celeste

          • June 1, 2015 at 1:52 am
          Bubbles
          Participant

            Thanks for sharing, Maggie!  Here is the synopsis of an artice from ASCO from the CheckMate 069 study…ipi plus nivo vs ipi alone.  It had a little bit different take on what groups experienced a higher response rate for the combo.  Hopefully things will become clearer as to what meds or combo's work best for which patients soon.  http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2015/05/asco-2015-nivo-plus-ipi-vs-ipi-alone.html

            Wishing you all my best.  Celeste

            • June 1, 2015 at 2:04 am
            CHD
            Participant

              Do either of you know if this also applies to mucosal melanoma patients?

                • June 1, 2015 at 2:31 am
                Bubbles
                Participant

                  I looked back but couldn't find any data specific to mucosal melanoma patients.  However, when the ipi/nivo combo was opened up in expanded access in 2014, patients with mucosal melanoma and those with treated brain mets WERE ALLOWED!  So it stands to reason that those patients are within these response rates as well.  Furthermore, there were 2 patients whose primaries were mucosal in my Nivo NED trial.  For what it's worth.  C

                  • June 1, 2015 at 5:38 pm
                  CHD
                  Participant

                    That's actually very encouraging, both for MM and brain mets patients!  Thank you.

                    • June 1, 2015 at 5:38 pm
                    CHD
                    Participant

                      That's actually very encouraging, both for MM and brain mets patients!  Thank you.

                      • June 1, 2015 at 5:38 pm
                      CHD
                      Participant

                        That's actually very encouraging, both for MM and brain mets patients!  Thank you.

                        • June 1, 2015 at 2:31 am
                        Bubbles
                        Participant

                          I looked back but couldn't find any data specific to mucosal melanoma patients.  However, when the ipi/nivo combo was opened up in expanded access in 2014, patients with mucosal melanoma and those with treated brain mets WERE ALLOWED!  So it stands to reason that those patients are within these response rates as well.  Furthermore, there were 2 patients whose primaries were mucosal in my Nivo NED trial.  For what it's worth.  C

                          • June 1, 2015 at 2:31 am
                          Bubbles
                          Participant

                            I looked back but couldn't find any data specific to mucosal melanoma patients.  However, when the ipi/nivo combo was opened up in expanded access in 2014, patients with mucosal melanoma and those with treated brain mets WERE ALLOWED!  So it stands to reason that those patients are within these response rates as well.  Furthermore, there were 2 patients whose primaries were mucosal in my Nivo NED trial.  For what it's worth.  C

                          • June 1, 2015 at 2:04 am
                          CHD
                          Participant

                            Do either of you know if this also applies to mucosal melanoma patients?

                            • June 1, 2015 at 2:04 am
                            CHD
                            Participant

                              Do either of you know if this also applies to mucosal melanoma patients?

                          Viewing 5 reply threads
                          • You must be logged in to reply to this topic.
                          About the MRF Patient Forum

                          The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                          The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                          Popular Topics